RESEARCH-USE BIOSIMILAR ANTIBODY
Ocaratuzumab
Monoclonal antibody · IgG1
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).
TARGETMS4A1
YMonoclonal antibody
CATALOGSC-BS-329
CATALOG NUMBERSC-BS-329
MOLECULAR WEIGHTApprox. 145.38 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).
Ocaratuzumab is a recombinant research-use antibody directed against MS4A1.